News

  1. Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape 12/30/2024

    The global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report "COVID-19: Global Clinical Trial Landscape 2024."

  2. OpenClinica Named Top Contender In Electronic Data Capture (EDC) Platforms By Everest Group 12/13/2024

    Everest Group, a leading global research and consulting firm, named OpenClinica a Major Contender in its Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment for 2024. The inaugural assessment evaluated 20 best-in-class EDCs based on the impact created in the market and the ability to deliver products successfully. OpenClinica differentiates itself from other EDCs with its vision and capability, earning high marks in technology capability, flexibility and ease of deployment, engagement and commercial model, and customer support.

  3. OpenClinica Debuts Secure, Participant-Friendly Mobile App For Direct Health Record Sharing In Clinical Research 12/13/2024

    OpenClinica Share™ simplifies the sharing of real-world and complex medical data for clinical research by participants.

  4. Signant Health Names Krishna Maridi, A Finance Leader With Over 25 Years Of Experience, As Chief Financial Officer 12/11/2024

    Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Krishna Maridi as chief financial officer.

  5. OpenClinica Acquires BuildClinical to Accelerate Patient Recruitment 12/10/2024

    OpenClinica today announced its acquisition of BuildClinical, a health technology company that helps researchers and patients find each other faster. BuildClinical uses advanced data-driven strategies to engage and enroll the ideal clinical trial population needed for a given study. Since its founding in 2020, BuildClinical has successfully enrolled more than 50,000 participants in clinical research studies, while simultaneously accelerating enrollment timelines and reducing participant engagement costs.

  6. Novotech Publishes Comprehensive Report On The Global Vaccine Clinical Trials Landscape 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders.

  7. Novotech Releases Report On Global Bladder Cancer Clinical Trials, Offering Insights For Oncology Advancement 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors. 

  8. Novotech Releases Comprehensive Report On The Global Clinical Trial Landscape For Small Cell Lung Cancer (SCLC) 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024, providing an in-depth analysis of current trends, challenges, and opportunities in SCLC clinical trials worldwide.

  9. The Future Of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights From Global Research 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, shares new insights into the global clinical trial landscape for Diffuse Large B-Cell Lymphoma (DLBCL), further reinforcing its leadership in oncology research.

  10. Global Cell And Gene Therapy Trials: Driving Innovation In Oncology And Beyond 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly evolving field of cell and gene therapies. The report provides critical insights into the growth of clinical trials, innovations and strategic opportunities, shaping the future of this field.